SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 14, 2002
Questcor Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
| California |
|
0-20772 |
|
33-0476164 |
| |
|
|
|
|
| (State or other jurisdiction of incorporation |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
|
|
|
|
3260 Whipple Road |
|
|
|
|
|
Union City, CA 94587 |
|
|
|
|
|
|
|
|
|
|
|
(Address of principal executive offices) |
|
|
|
|
|
|
|
|
|
|
|
(510) 400-0700 |
|
|
|
|
|
|
|
|
|
|
|
(Registrant’s telephone number, including area code) |
|
|
ITEM 9. REGULATION FD DISCLOSURE
On August 14, 2002, Questcor Pharmaceuticals, Inc. filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2002 (the “Form 10-Q”) with the Securities and Exchange Commission. Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the following certifications are being made to accompany the Form 10-Q:
Certification of Chief Executive Officer
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Questcor Pharmaceuticals, Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:
|
|
(i) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2002 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and | |
|
|
| |
|
|
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. | |
|
|
| |
|
|
Dated: August 14, 2002 |
/s/ CHARLES J. CASAMENTO |
|
|
|
Charles J. Casamento |
|
|
|
Chief Executive Officer |
|
|
|
|
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Certification of Chief Financial Officer
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Questcor Pharmaceuticals, Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:
|
|
(i) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2002 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
|
|
|
|
|
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
-2-
|
|
Dated: August 14, 2002 |
/s/ TIMOTHY E. MORRIS |
|
|
|
Timothy E. Morris |
|
|
|
Chief Financial Officer |
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
-3-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: August 14, 2002 |
QUESTCOR PHARMACEUTICALS, INC. | |||
|
|
|
|
| |
|
|
|
|
| |
|
|
|
By: |
/s/ TIMOTHY E. MORRIS | |
|
|
|
|
| |
|
|
|
|
Timothy E. Morris | |
|
|
|
|
Chief Financial Officer | |
-4-